14-day Premium Trial Subscription Try For FreeTry Free
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
On CNBC’s "Halftime Report: Final Trades," Shannon Saccocia of Boston Private said Quest Diagnostics Inc (NYSE: DGX) is expected to grow 4% to ...

Here's Why You Should Retain Quest Diagnostics (DGX) Stock Now

02:18pm, Friday, 23'rd Dec 2022 Zacks Investment Research
Investors are optimistic about Quest Diagnostics (DGX) on strong growth in the base business.

Final Trades: Quest Diagnostics, Treasurys & more

03:33pm, Thursday, 22'nd Dec 2022
The "Halftime Report" traders give their top picks to watch for the second half.

Where Quest Diagnostics Stands With Analysts

05:04pm, Wednesday, 14'th Dec 2022 Benzinga
Analysts have provided the following ratings for Quest Diagnostics (NYSE:DGX) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 0 2 0 1

Take the Zacks Approach to Beat the Market: NVIDIA, Boeing, Amgen in Focus

01:05pm, Monday, 12'th Dec 2022 Zacks Investment Research
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.

Quest Diagnostics' (DGX) New Deal to Extend Laboratory Access

03:53pm, Friday, 09'th Dec 2022 Zacks Investment Research
Quest Diagnostics' (DGX) new collaboration with Northern Light Health will enhance access to diagnostics services in Maine.
Quest Diagnostics' (DGX) new collaboration with Northern Light Health will enhance access to diagnostics services in Maine.

CVS Health: Acquisitions May Not Create True Value

08:19am, Thursday, 08'th Dec 2022 Seeking Alpha
CVS Health Corporation's last Q3 report underlines great revenue and free cash flow growth. Click here to read why my rating for CVS stock is a Buy.

Quest Diagnostics (DGX) Volume Growth Aids, Margin Woes Stay

05:53pm, Tuesday, 06'th Dec 2022 Zacks Investment Research
Quest Diagnostics' (DGX) legacy base business is growing amid softer utilization trends.
Quest Diagnostics' (DGX) legacy base business is growing amid softer utilization trends.

Beat the Market the Zacks Way: Tenaris, Lululemon, AutoZone in Focus

11:58am, Monday, 28'th Nov 2022 Zacks Investment Research
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Upgrades Wolfe Research upgraded the previous rating for Matson Inc (NYSE:MATX) from Underperform to Peer Perform. In the third quarter, Matson showed an EPS of $6.89, compared to $6.53 from the year-
Citigroup cut Quest Diagnostics Incorporated (NYSE: DGX) price target from $145 to $125. . Citigroup analyst Patrick Donnelly downgraded the stock from Neutral to Sell. Quest Diagnostics shares rose

Where Quest Diagnostics Stands With Analysts

12:03pm, Thursday, 17'th Nov 2022 Benzinga
Analysts have provided the following ratings for Quest Diagnostics (NYSE:DGX) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 0 3 0 1
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE